New USDA Report Identifies Wildfire Risk to Rural Communities

Mar 27, 2025

A newly-released report from the U.S. Department of Agriculture Economic Research Service (USDA ERS) is drawing attention to a growing concern across the country: wildfires. Specific focus in the study was placed on documenting the number and share of people over the age of 60 living in high wildfire risk areas. Additionally, it highlighted how the aging population combined with wildfire risk has increased the number of older people exposed to wildfire risk since 2010. For farmers across the country, especially in rural areas, the report’s findings reveal important data which were presented before wildfires impacted Oklahoma and Texas in mid-March, and just months after the massive destruction in California.

In a report summary prepared by the USDA Economic Research Service in February, authors Richelle L. Winkler and Miranda H. Mockrin zero in on 7 key findings. Excerpts from that report are provided here.

Writing in “Aging and Wildfire Risk to Communities,” Winkler, a USDA ERS research social scientist and Mockrin, a research scientist with the USDA, Forest Service, offered this:

Click here to see more...

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.